New Brunswick (1)

Acute Myeloid Leukemia (1)

Chronic Myelomonocytic Leukemia (1)

Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells (1)

Myelodysplastic Syndrome (1)

Myeloproliferative Neoplasm (1)

Recurrent Acute Myeloid Leukemia (1)

Refractory Acute Myeloid Leukemia (1)

Secondary Acute Myeloid Leukemia (1)

Recruiting (1)

phase 2 (1)

Rutgers, The State University of New Jersey (1)

National Cancer Institute (NCI) (1)

azacitidine (1)

decitabine (1)

salsalate (1)

venetoclax (1)

drug (1)

Other (1)

Interventional (1)

myeloblasts 10 percent or more of bone marrow nucleated cells

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

May 16, 2022